# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-091764
Filing Date
2024-08-06
Accepted
2024-08-06 16:05:29
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | hrtx-20240630.htm iXBRL | 10-Q | 1432049
2 | EX-31.1 | hrtx-ex31_1.htm | EX-31.1 | 15545
3 | EX-31.2 | hrtx-ex31_2.htm | EX-31.2 | 15352
4 | EX-32.1 | hrtx-ex32_1.htm | EX-32.1 | 16563
| Complete submission text file | 0000950170-24-091764.txt |  | 6779919

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20240630.xsd | EX-101.SCH | 938894
60 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20240630_htm.xml | XML | 1297772

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 241179108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)